Lv21
145 积分 2021-04-25 加入
AI-driven discovery of GPNMB CAR T cells as a multi-cancer therapy
5小时前
待确认
FIH dose selection beyond MABEL: Optimizing phase 1 clinical trial starting dose whilst protecting patient safety
12天前
已完结
Enhanced pre- and postnatal developmental toxicity (ePPND) study in non-human primates: Necessity, strategic approaches, and critical considerations
4个月前
已完结
Trends in target novelty in oncology R&D
5个月前
已完结
Strategies to reduce the use of non-human primates in the development of oncology therapeutics: CD3-bispecifics
7个月前
已完结
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B
7个月前
已完结
Ad hoc antibody modification of a validated flow cytometric immunophenotyping panel—recommendations and safeguards for clinical laboratories
8个月前
已完结
Prediction of First-in-Human Dose of Chimeric Antigen Receptor-T (CAR-T) Cells from Mice
8个月前
已完结
Evaluation of multiple immunoassay formats for detection of anti-drug antibodies to zinpentraxin alfa
8个月前
已完结
Defining immune reset: achieving sustained remission in autoimmune diseases
8个月前
已完结
皖公网安备34019202002308
